APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepcidin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hepcidin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025178 pages

Choose your research edition.

Industry ResearchHepcidin Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepcidin Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Hepcidin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepcidin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepcidin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Hepcidin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepcidin include Protagonist Therapeutics Inc, Pieris Pharmaceuticals Inc, Noxxon Pharma AG and Daiichi Sankyo Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hepcidin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hepcidin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepcidin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hepcidin market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepcidin Segment by Company

Protagonist Therapeutics Inc

Pieris Pharmaceuticals Inc

Noxxon Pharma AG

Daiichi Sankyo Co Ltd

Hepcidin Segment by Type

PTG-300

PRS-080

M-009

DS-79182026

Others

Hepcidin Segment by Application

Acute Inflammation

Sickle Cell Disease

Anemia

Iron Deficiency Anemia

Others

Hepcidin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepcidin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepcidin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepcidin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hepcidin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepcidin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hepcidin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hepcidin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hepcidin Industry Trends Table 2. Hepcidin Industry Drivers Table 3. Hepcidin Industry Opportunities and Challenges Table 4. Hepcidin Industry Restraints Table 5. Global Hepcidin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hepcidin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hepcidin Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hepcidin Sales Market Share by Manufacturers Table 9. Global Hepcidin Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hepcidin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hepcidin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hepcidin Manufacturers, Product Type & Application Table 13. Global Hepcidin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hepcidin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PTG-300 Table 17. Major Manufacturers of PRS-080 Table 18. Major Manufacturers of M-009 Table 19. Major Manufacturers of DS-79182026 Table 20. Major Manufacturers of Others Table 21. Global Hepcidin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Hepcidin Sales by Type (2021-2026) & (k units) Table 23. Global Hepcidin Sales by Type (2027-2032) & (k units) Table 24. Global Hepcidin Sales Market Share by Type (2021-2026) Table 25. Global Hepcidin Sales Market Share by Type (2027-2032) Table 26. Global Hepcidin Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Hepcidin Revenue by Type (2021-2026) & (k units) Table 28. Global Hepcidin Revenue by Type (2027-2032) & (k units) Table 29. Global Hepcidin Revenue Market Share by Type (2021-2026) Table 30. Global Hepcidin Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Acute Inflammation Table 32. Major Manufacturers of Sickle Cell Disease Table 33. Major Manufacturers of Anemia Table 34. Major Manufacturers of Iron Deficiency Anemia Table 35. Major Manufacturers of Others Table 36. Global Hepcidin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Hepcidin Sales by Application (2021-2026) & (k units) Table 38. Global Hepcidin Sales by Application (2027-2032) & (k units) Table 39. Global Hepcidin Sales Market Share by Application (2021-2026) Table 40. Global Hepcidin Sales Market Share by Application (2027-2032) Table 41. Global Hepcidin Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Hepcidin Revenue by Application (2021-2026) & (k units) Table 43. Global Hepcidin Revenue by Application (2027-2032) & (k units) Table 44. Global Hepcidin Revenue Market Share by Application (2021-2026) Table 45. Global Hepcidin Revenue Market Share by Application (2027-2032) Table 46. Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Hepcidin Sales by Region (2021-2026) & (k units) Table 48. Global Hepcidin Sales Market Share by Region (2021-2026) Table 49. Global Hepcidin Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Hepcidin Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Hepcidin Sales by Country (2021-2026) & (k units) Table 53. North America Hepcidin Sales by Country (2027-2032) & (k units) Table 54. Europe Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Hepcidin Sales by Country (2021-2026) & (k units) Table 56. Europe Hepcidin Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Hepcidin Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Hepcidin Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Hepcidin Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Hepcidin Sales by Country (2027-2032) & (k units) Table 63. Global Hepcidin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Hepcidin Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Hepcidin Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Hepcidin Revenue Market Share by Region (2021-2026) Table 67. Global Hepcidin Revenue Market Share by Region (2027-2032) Table 68. Protagonist Therapeutics Inc Company Information Table 69. Protagonist Therapeutics Inc Business Overview Table 70. Protagonist Therapeutics Inc Hepcidin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Protagonist Therapeutics Inc Hepcidin Product Portfolio Table 72. Protagonist Therapeutics Inc Recent Development Table 73. Pieris Pharmaceuticals Inc Company Information Table 74. Pieris Pharmaceuticals Inc Business Overview Table 75. Pieris Pharmaceuticals Inc Hepcidin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pieris Pharmaceuticals Inc Hepcidin Product Portfolio Table 77. Pieris Pharmaceuticals Inc Recent Development Table 78. Noxxon Pharma AG Company Information Table 79. Noxxon Pharma AG Business Overview Table 80. Noxxon Pharma AG Hepcidin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Noxxon Pharma AG Hepcidin Product Portfolio Table 82. Noxxon Pharma AG Recent Development Table 83. Daiichi Sankyo Co Ltd Company Information Table 84. Daiichi Sankyo Co Ltd Business Overview Table 85. Daiichi Sankyo Co Ltd Hepcidin Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Daiichi Sankyo Co Ltd Hepcidin Product Portfolio Table 87. Daiichi Sankyo Co Ltd Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Hepcidin Distributors List Table 91. Hepcidin Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Hepcidin Product Image Figure 2. Global Hepcidin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepcidin Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepcidin Sales (2021-2032) & (k units) Figure 5. Global Hepcidin Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hepcidin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PTG-300 Image Figure 9. PRS-080 Image Figure 10. M-009 Image Figure 11. DS-79182026 Image Figure 12. Others Image Figure 13. Global Hepcidin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hepcidin Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hepcidin Sales Market Share by Type (2021-2032) Figure 16. Global Hepcidin Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Hepcidin Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Hepcidin Revenue Market Share by Type (2021-2032) Figure 19. Acute Inflammation Image Figure 20. Sickle Cell Disease Image Figure 21. Anemia Image Figure 22. Iron Deficiency Anemia Image Figure 23. Others Image Figure 24. Global Hepcidin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Hepcidin Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hepcidin Sales Market Share by Application (2021-2032) Figure 27. Global Hepcidin Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Hepcidin Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Hepcidin Revenue Market Share by Application (2021-2032) Figure 30. North America Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Hepcidin Sales Market Share by Country (2021-2032) Figure 32. U.S. Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Hepcidin Sales Market Share by Country (2021-2032) Figure 37. Germany Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Hepcidin Sales Market Share by Country (2021-2032) Figure 44. China Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Hepcidin Sales Market Share by Country (2021-2032) Figure 52. Brazil Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Hepcidin Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Hepcidin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Hepcidin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Hepcidin Revenue (2021-2032) & (US$ Million) Figure 63. North America Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Hepcidin Revenue (2021-2032) & (US$ Million) Figure 65. Europe Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Hepcidin Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Hepcidin Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Hepcidin Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Hepcidin Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • PTG-300
  • PRS-080
  • M-009
  • DS-79182026
  • Others
Applications
  • Acute Inflammation
  • Sickle Cell Disease
  • Anemia
  • Iron Deficiency Anemia
  • Others
Companies covered
  • Protagonist Therapeutics Inc
  • Pieris Pharmaceuticals Inc
  • Noxxon Pharma AG
  • Daiichi Sankyo Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hepcidin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hepcidin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hepcidin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hepcidin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hepcidin Market Dynamics
  1. 2.1 Hepcidin Industry Trends
  2. 2.2 Hepcidin Industry Drivers
  3. 2.3 Hepcidin Industry Opportunities and Challenges
  4. 2.4 Hepcidin Industry Restraints
3 Hepcidin Market by Manufacturers
  1. 3.1 Global Hepcidin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hepcidin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hepcidin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hepcidin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepcidin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hepcidin Manufacturers, Product Type & Application
  7. 3.7 Global Hepcidin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepcidin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepcidin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepcidin Tier 1, Tier 2, and Tier 3
4 Hepcidin Market by Type
  1. 4.1 Hepcidin Type Introduction
  2. 4.1.1 PTG-300
  3. 4.1.2 PRS-080
  4. 4.1.3 M-009
  5. 4.1.4 DS-79182026
  6. 4.1.5 Others
  7. 4.2 Global Hepcidin Sales by Type
  8. 4.2.1 Global Hepcidin Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hepcidin Sales by Type (2021-2032)
  10. 4.2.3 Global Hepcidin Sales Market Share by Type (2021-2032)
  11. 4.3 Global Hepcidin Revenue by Type
  12. 4.3.1 Global Hepcidin Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hepcidin Revenue by Type (2021-2032)
  14. 4.3.3 Global Hepcidin Revenue Market Share by Type (2021-2032)
5 Hepcidin Market by Application
  1. 5.1 Hepcidin Application Introduction
  2. 5.1.1 Acute Inflammation
  3. 5.1.2 Sickle Cell Disease
  4. 5.1.3 Anemia
  5. 5.1.4 Iron Deficiency Anemia
  6. 5.1.5 Others
  7. 5.2 Global Hepcidin Sales by Application
  8. 5.2.1 Global Hepcidin Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Hepcidin Sales by Application (2021-2032)
  10. 5.2.3 Global Hepcidin Sales Market Share by Application (2021-2032)
  11. 5.3 Global Hepcidin Revenue by Application
  12. 5.3.1 Global Hepcidin Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Hepcidin Revenue by Application (2021-2032)
  14. 5.3.3 Global Hepcidin Revenue Market Share by Application (2021-2032)
6 Global Hepcidin Sales by Region
  1. 6.1 Global Hepcidin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hepcidin Sales by Region (2021-2032)
  3. 6.2.1 Global Hepcidin Sales by Region (2021-2026)
  4. 6.2.2 Global Hepcidin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hepcidin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hepcidin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hepcidin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hepcidin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hepcidin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hepcidin Revenue by Region
  1. 7.1 Global Hepcidin Revenue by Region
  2. 7.1.1 Global Hepcidin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hepcidin Revenue by Region (2021-2026)
  4. 7.1.3 Global Hepcidin Revenue by Region (2027-2032)
  5. 7.1.4 Global Hepcidin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hepcidin Revenue (2021-2032)
  8. 7.2.2 North America Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hepcidin Revenue (2021-2032)
  11. 7.3.2 Europe Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hepcidin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hepcidin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hepcidin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Protagonist Therapeutics Inc
  2. 8.1.1 Protagonist Therapeutics Inc Company Information
  3. 8.1.2 Protagonist Therapeutics Inc Business Overview
  4. 8.1.3 Protagonist Therapeutics Inc Hepcidin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Protagonist Therapeutics Inc Hepcidin Product Portfolio
  6. 8.1.5 Protagonist Therapeutics Inc Recent Developments
  7. 8.2 Pieris Pharmaceuticals Inc
  8. 8.2.1 Pieris Pharmaceuticals Inc Company Information
  9. 8.2.2 Pieris Pharmaceuticals Inc Business Overview
  10. 8.2.3 Pieris Pharmaceuticals Inc Hepcidin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pieris Pharmaceuticals Inc Hepcidin Product Portfolio
  12. 8.2.5 Pieris Pharmaceuticals Inc Recent Developments
  13. 8.3 Noxxon Pharma AG
  14. 8.3.1 Noxxon Pharma AG Company Information
  15. 8.3.2 Noxxon Pharma AG Business Overview
  16. 8.3.3 Noxxon Pharma AG Hepcidin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Noxxon Pharma AG Hepcidin Product Portfolio
  18. 8.3.5 Noxxon Pharma AG Recent Developments
  19. 8.4 Daiichi Sankyo Co Ltd
  20. 8.4.1 Daiichi Sankyo Co Ltd Company Information
  21. 8.4.2 Daiichi Sankyo Co Ltd Business Overview
  22. 8.4.3 Daiichi Sankyo Co Ltd Hepcidin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Daiichi Sankyo Co Ltd Hepcidin Product Portfolio
  24. 8.4.5 Daiichi Sankyo Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hepcidin Value Chain Analysis
  2. 9.1.1 Hepcidin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hepcidin Production Mode & Process
  6. 9.2 Hepcidin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hepcidin Distributors
  9. 9.2.3 Hepcidin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst